|Videos|June 15, 2021
Deep Dive: Deep Dive into Amivantamab
Dr. Joshua Sabari discussed the recent FDA approval of amivantamab to treat patients with metastatic non-small cell lung cancer with epidermal growth factor receptor (EGFR) exon 20 insertion mutations.
Related Articles
Deep Dive: Into Improving Patient Outcomes Through AIAugust 16th 2023
Behind the Science: Behind Chemotherapy ShortagesAugust 15th 2023
Deep Dive: Into Types of ChromatographyAugust 15th 2023
Deep Dive: Into Clinical Trials & Reproductive HealthAugust 4th 2023
Deep Dive: Into Diabetic RetinopathyAugust 3rd 2023
Deep Dive: Into AHN’s Fertility ClinicAugust 2nd 2023
